Life Science Today

Originally Published as The Niche Podcast

Gilead gets FDA approval in oncology, Bio-Techne acquires Asuragen, AI for tumor targeting, and Achilles completes $175M IPO.


Sponsors
https://www.thescopemethod.com


Story References
https://tinyurl.com/Niche-044-1
https://tinyurl.com/Niche-044-2
https://tinyurl.com/Niche-044-3
https://tinyurl.com/Niche-044-4


Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Originally Published as The Niche Podcast

Charles River acquires Retrogenix, IQVIA fully acquires Q2 Solutions, Agios sells $1.8B in oncology, and Alloy forges a $75M series C.


Sponsors
https://www.thescopemethod.com

 
Story References
https://tinyurl.com/Niche-043-1
https://tinyurl.com/Niche-043-2
https://tinyurl.com/Niche-043-3
https://tinyurl.com/Niche-043-4
https://tinyurl.com/Niche-043-5

 
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Originally Published as The Niche Podcast

This is our March bonus episode. I sit down with Dr. Benjamin  Schwartz an orthopedic surgeon and digital health expert. We talk digital integration, healthcare cost, and how you can get involved in the space.

Sponsors
https://www.thescopemethod.com

Guest  References
https://www.benschwartzmd.com/
https://www.linkedin.com/in/ben-schwartz-md/

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Originally Published as The Niche Podcast

Mergers in precision oncology testing, Medtronic breakthrough valve replacement, Gyroscope raises capital for AMD, and small molecule genetic treatments get $240M IPO.


Sponsors
https://www.thescopemethod.com

Story References
https://tinyurl.com/Niche-041-1
https://tinyurl.com/Niche-041-2
https://tinyurl.com/Niche-041-3
https://tinyurl.com/Niche-041-4

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Originally Published as The Niche Podcast

A new MS therapeutic, Fujifilm picks CDMO facility site, consolidation in medical services, and a new oncology startup.

Sponsors
https://www.thescopemethod.com
 

Story References
https://tinyurl.com/Niche-040-1
https://tinyurl.com/Niche-040-2
https://tinyurl.com/Niche-040-3
https://tinyurl.com/Niche-040-4

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Originally Published as The Niche Podcast

92% reduction in COVID mortality, AVEO gets FDA approval, Takeda acquires Maverick and targets emerging markets, and AgomAb raises $74M Series B for regenerative medicine.

Sponsors
https://www.thescopemethod.com


Story References
https://tinyurl.com/Niche-039-1
https://tinyurl.com/Niche-039-2
https://tinyurl.com/Niche-039-3
https://tinyurl.com/Niche-039-4
https://tinyurl.com/Niche-039-5
https://tinyurl.com/Niche-039-6
https://tinyurl.com/Niche-039-7


Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Originally Published as The Niche Podcast

Amgen nabs Five Prime Therapeutics in $1.9B deal, KemPharm ligates their way out of debt with ADHD, three failed COVID19 pipelines, and Colfax follows 2019 merger with corporate split.


Sponsors
https://www.thescopemethod.com


Story References
https://tinyurl.com/niche-038-1
https://tinyurl.com/niche-038-2
https://tinyurl.com/niche-038-3
https://tinyurl.com/niche-038-4


Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Originally Published as The Niche Podcast

I sit down with Dr. Mitrani, the Chief Scientific Officer for Organicell, a clinical stage biopharma company focused on regenerative medicine. Their leading product, Zofin is currently in early clinical trials for the treatment of COVID19. Eventually it may be a therapeutic for long haulers.


Key Talking Points
2:43 - Dr. Mitrani’s Journey to regenerative medicine
5:30 - From stem cells to nano medicine
8:12 - What is Zofin and how might it work?
9:46 - Pivoting into COVID19
11:42 - Following the science from stem cells to nano infusions
14:21 - Doing science is hard but we follow the data
19:59 - How following scientific data for years prepares you to pivot in response to crisis
25:40 - What trends have stood the test of time?
30:27 - How novel therapeutic spaces require novel approaches to product validation
34:11 - The work that is being done for COVID19 long-haulers


Sponsors
https://www.thescopemethod.com

Story References
https://organicell.com/

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Originally Published as The Niche Podcast

PRA acquired by Icon, Johnson & Johnson’s vaccine approved, Oncopeptides’ earns FDA approval, Roivant acquires Silicone Therapeutics, and Merck acquires Pandion.


Sponsors
https://www.thescopemethod.com


Story References
https://tinyurl.com/niche-036-1
https://tinyurl.com/niche-036-2
https://tinyurl.com/niche-036-3
https://tinyurl.com/niche-036-4
https://tinyurl.com/niche-036-5


Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Originally Published as The Niche Podcast

Eli Lilly bets on RIPK1, Charles River spends $875M on cell and gene therapy, Adjuvant Capital gets who’s who in backing, you can now buy an at-home COVID19 testing kit whenever you want, and Abbott does it again for the 389th time. 

Sponsors
https://www.thescopemethod.com

Story References
https://tinyurl.com/niche-35-1
https://tinyurl.com/niche-35-2
https://tinyurl.com/niche-35-3
https://tinyurl.com/niche-35-4
https://tinyurl.com/niche-35-5

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.